Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4112169)

Published in Arthritis Care Res (Hoboken) on August 01, 2014

Authors

Daniel H Solomon1, Chris Tonner, Bing Lu, Seoyoung C Kim, John Z Ayanian, M Alan Brookhart, Jeffrey N Katz, Ed Yelin

Author Affiliations

1: Brigham and Women's Hospital, Boston, Massachusetts.

Articles cited by this

A framework for the study of access to medical care. Health Serv Res (1974) 12.46

Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum (2002) 7.95

Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther (2011) 2.24

Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18

Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. JAMA (2011) 2.17

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum (1995) 1.92

Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr (1991) 1.76

Patients' problems with new medication for chronic conditions. Qual Saf Health Care (2004) 1.70

Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford) (2008) 1.59

Health outcomes for a chronic disease in prepaid group practice and fee for service settings. The case of rheumatoid arthritis. Med Care (1986) 1.20

Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res (2007) 1.16

Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey. Arthritis Care Res (Hoboken) (2012) 1.16

Health care utilization and outcomes among persons with rheumatoid arthritis in fee-for-service and prepaid group practice settings. JAMA (1996) 1.11

Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis. Clin Ther (2007) 1.09

Twelve-year trends in health insurance coverage among Latinos, by subgroup and immigration status. Health Aff (Millwood) (2006) 1.06

A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices. N Engl J Med (1985) 1.02

Depression treatment preferences of Hispanic individuals: exploring the influence of ethnicity, language, and explanatory models. J Am Board Fam Med (2011) 1.01

The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index. Control Clin Trials (1991) 0.89

Articles by these authors

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80

Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev (2004) 15.57

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum (2003) 6.68

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63

Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med (2009) 6.33

Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med (2005) 6.29

Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61

Physician performance and racial disparities in diabetes mellitus care. Arch Intern Med (2008) 5.04

Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am (2005) 4.90

The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One (2010) 4.75

Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50

Effect of cost sharing on screening mammography in Medicare health plans. N Engl J Med (2008) 4.48

Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am (2003) 4.38

Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ (2013) 4.17

The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. J Rheumatol (2002) 4.16

Cultural competency training and performance reports to improve diabetes care for black patients: a cluster randomized, controlled trial. Ann Intern Med (2010) 4.01

Implementing open-access scheduling of visits in primary care practices: a cautionary tale. Ann Intern Med (2008) 4.01

Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS (2010) 3.93

Impact of Medicare coverage on basic clinical services for previously uninsured adults. JAMA (2003) 3.93

Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med (2009) 3.84

The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.75

Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am (2004) 3.70

Altitude and all-cause mortality in incident dialysis patients. JAMA (2009) 3.62

Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57

Use of health services by previously uninsured Medicare beneficiaries. N Engl J Med (2007) 3.41

Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am (2003) 3.33

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33

Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum (2002) 3.29

Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med (2011) 3.27

Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst (2003) 3.21

Group exercise, education, and combination self-management in women with fibromyalgia: a randomized trial. Arch Intern Med (2007) 3.20

Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med (2011) 3.11

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04

Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01

The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am (2012) 2.98

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93

Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91

The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med (2013) 2.77

Trends in epidemiology of knee arthroplasty in the United States, 1990-2000. Arthritis Rheum (2005) 2.76

Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75

Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med (2008) 2.74

Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer (2006) 2.73

Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol (2003) 2.72

Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care (2003) 2.69

Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am (2005) 2.67

Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med (2009) 2.65

The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61

A new stage of the nutrition transition in China. Public Health Nutr (2002) 2.52

Relationship between quality of care and racial disparities in Medicare health plans. JAMA (2006) 2.49

Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47

Medicare spending for previously uninsured adults. Ann Intern Med (2009) 2.47

Perceived discrimination and use of preventive health services. J Gen Intern Med (2006) 2.45

Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42

Health of previously uninsured adults after acquiring Medicare coverage. JAMA (2007) 2.41

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med (2008) 2.40

Factors affecting influential discussions among physicians: a social network analysis of a primary care practice. J Gen Intern Med (2007) 2.39

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.37

Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med (2006) 2.36

Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med (2011) 2.35

Health insurance coverage and mortality among the near-elderly. Health Aff (Millwood) (2004) 2.35

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31

Rotator cuff disorders: recognition and management among patients with shoulder pain. Arthritis Rheum (2004) 2.28

Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care (2005) 2.28

Psychosocial stress and change in weight among US adults. Am J Epidemiol (2009) 2.26

Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care (2005) 2.25

Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther (2011) 2.24

Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol (2006) 2.24

Evidence of sample use among new users of statins: implications for pharmacoepidemiology. Med Care (2014) 2.22

Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22

Unintended consequences of eliminating medicare payments for consultations. JAMA Intern Med (2013) 2.21

Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab (2014) 2.18

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18

Patient characteristics and experiences associated with trust in specialist physicians. Arch Intern Med (2004) 2.17

Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12

Variations in hospice use among cancer patients. J Natl Cancer Inst (2006) 2.12

Clinical examination of the rotator cuff. PM R (2013) 2.11

Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol (2014) 2.11

Does this patient with a pericardial effusion have cardiac tamponade? JAMA (2007) 2.04

Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis (2003) 2.04

Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00

Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96

Orthopaedic procedure volume and patient outcomes: a systematic literature review. Clin Orthop Relat Res (2007) 1.96

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.95

Impact of hospital volume on racial disparities in cardiovascular procedure mortality. J Am Coll Cardiol (2006) 1.94

Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94

The validity of race and ethnicity in enrollment data for Medicare beneficiaries. Health Serv Res (2012) 1.93

Understanding the nutrition transition: measuring rapid dietary changes in transitional countries. Public Health Nutr (2002) 1.93

Control of hypertension in adults with chronic kidney disease in the United States. Hypertension (2005) 1.92

Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92

A comparison of total hip and knee replacement in specialty and general hospitals. J Bone Joint Surg Am (2007) 1.90

Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88

Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum (2002) 1.87

Estimating the burden of total knee replacement in the United States. J Bone Joint Surg Am (2013) 1.84